What is the enterprise number of REIVAX MD?

The enterprise number of REIVAX MD is BE1005195162.

What is the address of REIVAX MD?

The registered office of REIVAX MD is located at Heulestraat 48, 8560 Wevelgem.

When was REIVAX MD founded?

REIVAX MD was founded on 25 January 2024.

Does REIVAX MD have a website?

No website is currently known for REIVAX MD.

How much profit did REIVAX MD make in 2025?

REIVAX MD posted a profit after taxes of € 501,874 in financial year 2025.

What is the revenue of REIVAX MD?

As a small company, REIVAX MD is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 667,174.

Where can I find the annual accounts of REIVAX MD?

REIVAX MD files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of REIVAX MD?

According to the 2025 annual accounts, the directors of REIVAX MD are: Xavier-Philippe Aers.

REIVAX MD (Private Limited) - Wevelgem (8560) - BE1005195162

Financials

Financial year 2025

Gross margin

€ 667,174

▼ 12% vs 2024

Profit

Healthy

€ 501,874

▼ 5% vs 2024

Debts

Low

€ 675,912

▼ 5% vs 2024

REIVAX MD from Wevelgem, company number BE1005195162, closed financial year 2025 with a result of € 501,874 after tax. For that financial year REIVAX MD recorded a gross margin of € 667,174 and equity of € 1 million. Compared with financial year 2024, the result moved from € 529,073 to € 501,874. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What happened at REIVAX MD?

What happened at REIVAX MD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 501,874 (▼ 5% vs 2024). Source: NBB ↗
Jan 25, 2024 New establishment in Wevelgem. KBO
Jan 25, 2024 Start of the company according to the CBE. KBO

In short

From € 529,073 profit in 2024 to € 501,874 profit in 2025.

Paid € 330,668 in corporate taxes since 2024.

Best year ever: 2024, with € 529,073 profit.

Original PDFs at the National Bank ↗

A new publication or filing at REIVAX MD? We notify you, reason included.

Follow REIVAX MD

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Xavier-Philippe Aers

REIVAX MD

Hashimoto 25%

Behind REIVAX MD is Xavier-Philippe Aers. It owns 25% of Hashimoto itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Xavier-Philippe Aers

Director

Also active at: HASHIMOTO

Establishments

Establishment units

Physical locations of this company

Registered office

Heulestraat 48

8560 Wevelgem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

AMO-AD

€ 310,565 gross margin · 2025

Details

Company number: 1005.195.162
VAT number: BE 1005.195.162
Registered office: Heulestraat 48, 8560 Wevelgem
Names & denominations: REIVAX MD
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 January 2024
Peppol: Active · Active since 16 Jul 2026

View on CBE Public ↗ Annual accounts (NBB) ↗